It is part of our mission to research and pursue evidence-based treatments and cures for children.

The pediatric Neuro-Oncology Program is strongly supported by Johns Hopkins All Children's Cancer & Blood Disorders Institute and the Institute for Brain Protection Sciences. Specialists in both institutes work closely together to discuss patient care and clinical trial status, with neuro-oncology tumor boards held weekly and molecular tumor boards held monthly.

The Johns Hopkins All Children’s neuro-oncology faculty are board-certified in their specialties, have grant funding track records and prior experience as investigators in clinical trials and cohort studies. Stacie Stapleton, M.D., director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital, has been principal investigator on multiple investigator-initiated studies and has numerous grant funds. In addition to our comprehensive team of experts, the Neuro-Oncology Program benefits from being an affiliate of the H. Lee Moffitt Cancer Center & Research Institute.

Consortiums and Research Studies 

Johns Hopkins All Children's Hospital is a member of multiple consortiums and participates in multi-site studies pertaining to patients with central nervous system tumors. We have worked with several other multi-institutional consortiums by opening early-phase studies at our institution.

Learn more about research studies at Johns Hopkins All Children’s Hospital